IKENA ONCOLOGY INC's ticker is IKNA and the CUSIP is 45175G108. A total of 47 filers reported holding IKENA ONCOLOGY INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 2,249,123 | $63,538,000 | 6.01% |
| CHI Advisors LLC | 814,756 | $23,017,000 | 4.61% |
| Octagon Capital Advisors LP | 400,000 | $11,300,000 | 4.26% |
| BVF INC/IL | 1,599,658 | $45,190,000 | 1.69% |
| Logos Global Management LP | 419,853 | $11,861,000 | 1.16% |
| Orbimed Advisors | 2,933,941 | $82,884,000 | 0.78% |
| Artal Group S.A. | 1,549,513 | $43,774,000 | 0.77% |
| HealthCor Management, L.P. | 341,212 | $9,639,000 | 0.34% |
| RA Capital Management | 750,000 | $21,188,000 | 0.32% |
| Nantahala Capital Management | 325,000 | $9,181,000 | 0.27% |